Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
The Lancet. Oncology
|
July 3, 2026
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
Leonardo Brunetti, Valentina Santo, David J Pinato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study
Antoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Gut
|
December 30, 2022
Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines
Roy Hajjar, Emmanuel Gonzalez, Gabriela Fragoso, et al.
Oncoimmunology
|
April 7, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma
Ailin Lepletier, Jason Madore, Jake S O'Donnell, et al.
Cancer Discovery
|
January 15, 2022
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Meriem Messaoudene, Reilly Pidgeon, Corentin Richard, et al.
Cancer Cell
|
December 29, 2023
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
European Urology
|
May 8, 2020
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa, Bertrand Routy, Marine Fidelle, et al.
Molecular Cancer
|
September 6, 2024
Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
Léa Montégut, Peng Liu, Liwei Zhao, et al.
Immunity
|
October 9, 2016
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
The Lancet. Oncology
|
July 3, 2026
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
Leonardo Brunetti, Valentina Santo, David J Pinato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study
Antoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Gut
|
December 30, 2022
Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines
Roy Hajjar, Emmanuel Gonzalez, Gabriela Fragoso, et al.
Oncoimmunology
|
April 7, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma
Ailin Lepletier, Jason Madore, Jake S O'Donnell, et al.
Cancer Discovery
|
January 15, 2022
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Meriem Messaoudene, Reilly Pidgeon, Corentin Richard, et al.
Cancer Cell
|
December 29, 2023
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
European Urology
|
May 8, 2020
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa, Bertrand Routy, Marine Fidelle, et al.
Molecular Cancer
|
September 6, 2024
Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
Léa Montégut, Peng Liu, Liwei Zhao, et al.
Immunity
|
October 9, 2016
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Page
of 13